Chemical proteomics approaches are widely used to identify molecular targets of existing or novel drugs. This manuscript describes the development of a straightforward approach to conjugate azide-labeled drugs via click chemistry to alkyne-tagged cell-penetrating fluorescent nanoparticles as a novel tool to study target engagement and/or identification inside living cells. A modification of the Baeyer test for alkynes allows monitoring the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, guaranteeing the presence of the drug on the solid support. As a proof of concept, the conjugation of the promiscuous kinase inhibitor dasatinib to Cy5-labeled nanoparticles is presented. Dasatinib-decorated fluorescent nanoparticles efficiently inhibited its protein target SRC in vitro, entered cancer cells, and colocalized with SRC in cellulo.
CITATION STYLE
Valero, T., Delgado-González, A., Unciti-Broceta, J. D., Cano-Cortés, V., Pérez-López, A. M., Unciti-Broceta, A., & Sánchez Martín, R. M. (2018). Drug “clicking” on Cell-Penetrating Fluorescent Nanoparticles for in Cellulo Chemical Proteomics. Bioconjugate Chemistry, 29(9), 3154–3160. https://doi.org/10.1021/acs.bioconjchem.8b00481
Mendeley helps you to discover research relevant for your work.